|
US3239345A
(en)
|
1965-02-15 |
1966-03-08 |
|
Estrogenic compounds and animal
growth promoters |
|
US4411890A
(en)
|
1981-04-14 |
1983-10-25 |
Beckman Instruments, Inc. |
Synthetic peptides having pituitary growth hormone releasing activity
|
|
US4036979A
(en)
|
1974-01-25 |
1977-07-19 |
American Cyanamid Company |
Compositions containing 4,5,6,7-tetrahydrobenz[b]thien-4-yl-ureas or derivatives and methods of enhancing growth rate
|
|
JPH03502326A
(ja)
|
1988-01-28 |
1991-05-30 |
ポリゲン ホールディング コーポレイション |
成長ホルモン放出活性を有するポリペプチド化合物類
|
|
ATE122357T1
(de)
|
1988-01-28 |
1995-05-15 |
Polygen Holding Corp |
Polypeptide mit hormonwachstumsbefreiender wirkung.
|
|
JP2670680B2
(ja)
|
1988-02-24 |
1997-10-29 |
株式会社ビーエムジー |
生理活性物質含有ポリ乳酸系微小球およびその製造法
|
|
WO1992007578A1
(en)
|
1990-10-25 |
1992-05-14 |
Genentech, Inc. |
Use of protective agents against reactive oxygen species
|
|
US5663146A
(en)
|
1991-08-22 |
1997-09-02 |
Administrators Of The Tulane Educational Fund |
Polypeptide analogues having growth hormone releasing activity
|
|
JPH08503213A
(ja)
|
1992-11-06 |
1996-04-09 |
メルク エンド カンパニー インコーポレーテッド |
成長ホルモンの放出を促進する置換ジペプチド同族体
|
|
US5726319A
(en)
|
1992-11-06 |
1998-03-10 |
Merck & Co., Inc. |
Biphenyl substituted dipeptide analogs promote release of growth hormone
|
|
US5536716A
(en)
|
1992-12-11 |
1996-07-16 |
Merck & Co., Inc. |
Spiro piperidines and homologs which promote release of growth hormone
|
|
CZ151495A3
(en)
|
1992-12-11 |
1995-12-13 |
Merck & Co Inc |
Spiropiperidine derivatives, process of their preparation and a pharmaceutical composition containing thereof
|
|
EP0813414A4
(en)
|
1993-10-19 |
1999-07-21 |
Merck & Co Inc |
Combination of bisphosphonates and growth hormone secretagogues
|
|
US5494919A
(en)
|
1993-11-09 |
1996-02-27 |
Merck & Co., Inc. |
2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
|
|
US5492916A
(en)
|
1993-12-23 |
1996-02-20 |
Merck & Co., Inc. |
Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
|
|
PL322706A1
(en)
|
1993-11-09 |
1998-02-16 |
Merck & Co Inc |
Piperidines, pyrolidines and hexahydro-1h-azepins enhancing growth hormone liberation
|
|
WO1995014666A1
(en)
|
1993-11-24 |
1995-06-01 |
Merck & Co., Inc. |
Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s)
|
|
US5721251A
(en)
|
1993-12-10 |
1998-02-24 |
Merck & Co., Inc. |
Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone
|
|
US5721250A
(en)
|
1993-12-23 |
1998-02-24 |
Merck & Co. Inc. |
Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
|
|
HU221092B1
(en)
|
1993-12-23 |
2002-08-28 |
Novo Nordisk As |
Compounds with growth hormone releasing properties
|
|
PT736039E
(pt)
|
1993-12-23 |
2001-04-30 |
Novo Nordisk As |
Compostos com propriedades para liberar a hormona de crescimento
|
|
US5777112A
(en)
|
1994-06-13 |
1998-07-07 |
Merck & Co., Inc |
Piperazine compounds promote release of growth hormone
|
|
WO1996002530A1
(en)
|
1994-07-20 |
1996-02-01 |
Merck & Co., Inc. |
Piperidines and hexahydro-1h-azepines spiro substituted at the 4-position promote release of growth hormone
|
|
US5798337A
(en)
|
1994-11-16 |
1998-08-25 |
Genentech, Inc. |
Low molecular weight peptidomimetic growth hormone secretagogues
|
|
AU4495996A
(en)
|
1995-01-25 |
1996-08-14 |
Nippon Chemiphar Co. Ltd. |
Dihydrophenazine derivatives
|
|
DE69633003T2
(de)
|
1995-01-27 |
2005-08-18 |
Novo Nordisk A/S |
Verbindungen mit wachstumshormon-freisetzenden eigenschaften
|
|
AU4534596A
(en)
|
1995-02-09 |
1996-08-27 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
WO1996024587A1
(en)
|
1995-02-09 |
1996-08-15 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
US5559128A
(en)
|
1995-04-18 |
1996-09-24 |
Merck & Co., Inc. |
3-substituted piperidines promote release of growth hormone
|
|
AU5486396A
(en)
|
1995-04-19 |
1996-11-07 |
Merck & Co., Inc. |
Process for the preparation of spiroindolines
|
|
WO1996035713A1
(en)
|
1995-05-08 |
1996-11-14 |
Pfizer, Inc. |
Dipeptides which promote release of growth hormone
|
|
ATE288444T1
(de)
|
1995-05-29 |
2005-02-15 |
Pfizer |
Dipeptide, die die ausschüttung von wachstumshormonen stimulieren
|
|
BR9608909A
(pt)
|
1995-06-22 |
1999-03-02 |
Novo Nordisk As |
Composto composição farmacêutica processos para estimular a liberação do hormônio do crescimento da patuitária e aumentar a velocidade e extensão do crescimento dos animais para aumentar a produção de leite ou lã de animais ou para para doenças e uso do composto
|
|
CA2203424A1
(en)
|
1995-08-21 |
1997-02-27 |
Eli Lilly And Company |
2-acylaminopropanamines as growth hormone secretagogues
|
|
EP0761220A1
(en)
|
1995-08-21 |
1997-03-12 |
Eli Lilly And Company |
2-Acylaminopropanamides as growth hormone secretagogues
|
|
EP0766966A3
(en)
|
1995-09-08 |
2001-02-28 |
Eli Lilly And Company |
Method of treating insulin resistance
|
|
WO1997011697A1
(en)
|
1995-09-26 |
1997-04-03 |
Merck & Co., Inc. |
3-spirolactam, 3-spiroamino, 3-spirolactone and 3-spirobenzopyran piperidines and pyrrolidines promote release of growth hormone
|
|
JPH11513989A
(ja)
|
1995-10-27 |
1999-11-30 |
メルク エンド カンパニー インコーポレーテッド |
成長ホルモン分泌促進薬の湿式造粒製剤
|
|
US5723616A
(en)
|
1995-10-27 |
1998-03-03 |
Merck & Co., Inc. |
Process for the preparation of a growth hormone secretagogue
|
|
US5767124A
(en)
|
1995-10-27 |
1998-06-16 |
Merck & Co., Inc. |
Polymorphic forms of a growth hormone secretagogue
|
|
KR19990067097A
(ko)
|
1995-10-27 |
1999-08-16 |
폴락 돈나 엘. |
성장 호르몬 분비 촉진제의 제조 방법
|
|
ES2268713T3
(es)
|
1995-12-13 |
2007-03-16 |
MERCK & CO., INC. |
Ensayos de receptores de secretagogos de la hormona de crecimiento.
|
|
ATE279440T1
(de)
|
1995-12-13 |
2004-10-15 |
Merck & Co Inc |
Wachstumshormonsekretionsförderer rezeptorfamilie
|
|
IT1277113B1
(it)
|
1995-12-20 |
1997-11-04 |
Romano Deghenghi |
Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita
|
|
WO1997022367A1
(en)
|
1995-12-20 |
1997-06-26 |
Merck & Co., Inc. |
Radiolabeled growth hormone secretagogue
|
|
IL124702A0
(en)
*
|
1995-12-22 |
1998-12-06 |
Novo Nordisk As |
Compounds with growth hormone releasing properties
|
|
TW432073B
(en)
|
1995-12-28 |
2001-05-01 |
Pfizer |
Pyrazolopyridine compounds
|
|
AU2334097A
(en)
|
1996-03-21 |
1997-10-10 |
Merck & Co., Inc. |
4-spiroindoline piperidines promote release of growth hormone
|
|
WO1997036873A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
|
|
SE9601397D0
(sv)
|
1996-04-12 |
1996-04-12 |
Pharmacia Ab |
Use of growth hormone
|
|
WO1997040071A1
(en)
|
1996-04-19 |
1997-10-30 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
EP0907643B1
(en)
|
1996-04-24 |
2003-01-15 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
US5919777A
(en)
|
1996-04-24 |
1999-07-06 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
CA2253390A1
(en)
|
1996-05-07 |
1997-11-13 |
Merck & Co., Inc. |
Enhancement of sleep with a growth hormone secretagogue
|
|
AU2931997A
(en)
|
1996-05-07 |
1997-11-26 |
Merck & Co., Inc. |
Treatment of mood disorders with a growth hormone secretagogue
|
|
WO1997043278A1
(en)
|
1996-05-14 |
1997-11-20 |
Novo Nordisk A/S |
Somatostatin agonists and antagonists
|
|
US6071926A
(en)
|
1996-05-22 |
2000-06-06 |
Arch Development Corporation |
Sleep quality improvement using a growth hormone secretagogue
|
|
PL330239A1
(en)
|
1996-05-31 |
1999-05-10 |
Novo Nordisk As |
Growt hormone constituent and bone reserption preventing factor in cyclic (coherent) treatment
|
|
AU3434697A
(en)
|
1996-07-22 |
1998-02-10 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
AU4342097A
(en)
|
1996-09-13 |
1998-04-02 |
Merck & Co., Inc. |
Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
|
|
AU4993497A
(en)
|
1996-10-25 |
1998-05-22 |
Merck & Co., Inc. |
Convergent process for the preparation of a growth hormone secretagogue
|
|
SE9703929D0
(sv)
|
1996-11-22 |
1997-10-28 |
Pharmacia & Upjohn Ab |
Therapeutical use and method
|
|
AU6747498A
(en)
|
1997-04-11 |
1998-11-11 |
Sumitomo Pharmaceuticals Company, Limited |
Benzene derivatives
|
|
JP2000514838A
(ja)
|
1997-05-14 |
2000-11-07 |
藤沢薬品工業株式会社 |
成長ホルモンの放出を促進するピペリジノ誘導体
|
|
US5861149A
(en)
|
1997-06-04 |
1999-01-19 |
Polyheal Ltd. |
Methods for wound treatment
|
|
EP1005484A1
(en)
|
1997-06-20 |
2000-06-07 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
UA53716C2
(uk)
|
1997-06-25 |
2003-02-17 |
Пфайзер Продактс Інк. |
Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)
|
|
WO1998058947A1
(en)
|
1997-06-25 |
1998-12-30 |
Pfizer Inc. |
Dipeptide derivatives as growth hormone secretagogues
|
|
UA64751C2
(uk)
|
1997-06-25 |
2004-03-15 |
Пфайзер Продактс Інк. |
Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти)
|
|
ZA987383B
(en)
|
1997-08-19 |
2000-02-17 |
Lilly Co Eli |
Treatment of congestive heart failure with growth hormone secretagogues.
|
|
DE69836386T2
(de)
|
1997-08-22 |
2007-10-11 |
Kaken Pharmaceutical Co., Ltd. |
Amide zur Förderung der Ausschüttung von Wachstumshormonen
|
|
IL137007A0
(en)
|
1998-01-16 |
2001-06-14 |
Novo Nordisk As |
Compounds with growth hormone releasing properties
|
|
WO1999039730A1
(en)
|
1998-02-09 |
1999-08-12 |
Kaken Pharmaceutical Co., Ltd. |
Oral preparations containing peptides promoting the secretion of growth hormone
|
|
HUP0100998A3
(en)
|
1998-03-03 |
2001-12-28 |
Novo Nordisk As |
(2e)-5-amino-5-methylhex-2-enoic acid n-methyl-n-((1r)-1-(n-methyl-n-((1r)-1-(methylcarbamoyl)-2-phenylethyl)carbamoyl)-2-(2-naphtyl)ethyl)amide salts, methods for their preparation, pharmaceutical compositions comprising thereof and their use
|
|
PL194560B1
(pl)
|
1998-05-11 |
2007-06-29 |
Novo Nordisk As |
Związki o właściwościach uwalniania hormonu wzrostu, kompozycja farmaceutyczna zawierająca te związki oraz ich zastosowanie
|
|
JP4574849B2
(ja)
|
1998-06-09 |
2010-11-04 |
サファイア セラピューティクス,インコーポレイティド |
成長ホルモン放出特性を有する化合物を調製するための方法
|
|
HN1999000097A
(es)
|
1998-06-16 |
1999-11-03 |
Pfizer Prod Inc |
Terapia de combinacion para la fragilidad muscoloesqueletica
|
|
KR20010052817A
(ko)
|
1998-06-16 |
2001-06-25 |
실버스타인 아써 에이. |
근골격 무름을 치료하기 위한 선택적인 에스트로겐 수용체조절제 및 성장 호르몬 분비촉진제의 치료적 혼합물
|
|
CA2334315C
(en)
|
1998-06-30 |
2011-07-26 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
KR100680085B1
(ko)
|
1998-08-20 |
2007-02-28 |
다이닛본 스미토모 세이야꾸 가부시끼가이샤 |
성장호르몬 방출촉진제로서 옥신돌 유도체
|
|
US6358951B1
(en)
|
1998-08-21 |
2002-03-19 |
Pfizer Inc. |
Growth hormone secretagogues
|
|
AU2405401A
(en)
|
1999-12-28 |
2001-07-09 |
Kaken Pharmaceutical Co., Ltd. |
Nerve protective drugs
|
|
CA2411667A1
(en)
|
2000-05-30 |
2001-12-06 |
Merck & Co. Inc. |
Ghrelin analogs
|
|
ES2333097T3
(es)
|
2000-05-31 |
2010-02-17 |
Raqualia Pharma Inc |
Uso de secretagogos de la hormona de crecimiento para estimular la motilidad gastrointestinal.
|
|
CN1232507C
(zh)
|
2000-06-13 |
2005-12-21 |
曾塔里斯股份公司 |
生长激素促分泌剂
|
|
EP1297839A4
(en)
|
2000-06-23 |
2005-12-07 |
Kaken Pharma Co Ltd |
PREVENTIVA OR THERAPEUTIC AGAINST HEART FAILURE
|
|
ITMI20011445A1
(it)
|
2001-07-06 |
2003-01-06 |
Europ Geie |
Analoghi della cortistantina capaci di legarsi selettivamente ai recettori dei secretagoghi dell'ormone della crescita
|
|
CU23043A1
(es)
|
2001-12-20 |
2005-05-20 |
Ct Ingenieria Genetica Biotech |
Composicion farmaceutica que contiene factor de crecimiento epidrmico (egf) para la prevencion de la amputacion de pie diabetico.
|
|
US7476653B2
(en)
|
2003-06-18 |
2009-01-13 |
Tranzyme Pharma, Inc. |
Macrocyclic modulators of the ghrelin receptor
|
|
WO2005039625A1
(en)
|
2003-10-28 |
2005-05-06 |
Rheoscience A/S |
Growth hormone secretagogue receptor agonists
|
|
EP1682136A4
(en)
|
2003-11-04 |
2009-06-03 |
Elixir Pharmaceuticals Inc |
THERAPEUTIC COMPOUNDS AND CORRESPONDING USES THEREOF
|
|
WO2005048916A2
(en)
|
2003-11-20 |
2005-06-02 |
Biovitrum Ab |
Tetrahydrospiro-beta-carboline-1,3 '-pyrrolidine derivatives and their use in ghsr-related disorders
|